PWMAG
BCYC icon

Pinnacle Wealth Management Advisory Group’s Bicycle Therapeutics BCYC Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.6K Hold
10,985
– – ﹤0.01% 561
2026
Q1 		$51K Buy
10,985
+985
+10% +$5.63K ﹤0.01% 536
2025
Q4 		$70.8K Buy
+10,000
New +$73.7K ﹤0.01% 515

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's BCYC Position: Q2 2026 in Review

Pinnacle Wealth Management Advisory Group held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 10,985 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #561.

Pinnacle Wealth Management Advisory Group first reported a position in BCYC in Q4 2025 and has held it in 3 quarters since. The position peaked at $70.8K in Q4 2025. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Pinnacle Wealth Management Advisory Group held 10,985 shares of Bicycle Therapeutics worth $46.6K as of Q2 2026.
  • Pinnacle Wealth Management Advisory Group left its Bicycle Therapeutics share count unchanged in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #561 holding.
  • Pinnacle Wealth Management Advisory Group first reported a position in Bicycle Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Wealth Management Advisory Group's Bicycle Therapeutics position peaked at $70.8K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.